GlassScriptPhysician profile
Jaspreet Singh
NPI 1598859217
$307,530.83
in general payments reported to CMS, 2019-2025
68 companies · $38K in 2025
The $38K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $22K · 2021: $60K · 2022: $42K · 2023: $52K · 2024: $49K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $73K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Travel and Lodging: $15K · Food and Beverage: $7,661 · Education: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $73,181.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,060.00 |
| Travel and Lodging | $15,140.99 |
| Food and Beverage | $7,660.76 |
| Education | $606.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $201,673.03 | 2019-2024 | Ams 700 Cxr Rte Kit, Ams 700, Greenlight Xps |
| Coloplast Corp | $94,156.16 | 2019-2025 | Titan, Speedicath |
| Antares Pharma, INC. | $1,197.35 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Medtronic USA, INC. | $1,075.34 | 2020 | |
| Astellas Pharma US INC | $949.10 | 2019-2025 | Xtandi, Myrbetriq |
| Neotract INC. | $856.18 | 2019-2020 | |
| Teleflex LLC | $758.48 | 2022-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $460.31 | 2019-2025 | Erleada, Tremfya, Akeega |
| Medtronic, INC. | $414.46 | 2021-2025 | Interstim |
| Abbvie INC. | $413.04 | 2019-2024 | Botox, Lupron Depot |
| Bayer Healthcare Pharmaceuticals INC. | $360.72 | 2019-2024 | |
| Urogen Pharma, INC. | $350.09 | 2022-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $345.31 | 2023-2025 | Orgovyx, Gemtesa |
| Axonics, INC. | $315.85 | 2020-2023 | Axonics |
| Pfizer INC. | $255.99 | 2019-2024 |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $241.55 | 2019-2025 | Adstiladrin |
| Rigicon,INC. | $212.90 | 2023-2025 | Rigi10, Rigi10 Malleable Penile Prosthesis, Rigi10 Malleable Penile Prosthesis |
| Cardiovascular Systems INC. | $191.97 | 2023 | |
| Endo Pharmaceuticals INC. | $188.57 | 2019-2024 | Xiaflex, Aveed |
| Bard Access Systems, INC. | $176.28 | 2019 | |
| Myriad Genetic Laboratories, INC. | $169.51 | 2021-2025 | Prolaris, Myrisk |
| Alnylam Pharmaceuticals INC. | $142.94 | 2023-2024 | Givlaari |
| Progenics Pharmaceuticals, INC. | $129.02 | 2023-2025 | Pylarify |
| Novo Nordisk INC | $125.00 | 2021 | |
| Organogenesis INC. | $119.12 | 2019 | |
| Allergan, INC. | $118.59 | 2019-2021 | |
| Endo USA, INC. | $115.48 | 2024-2025 | Xiaflex, Aveed |
| Takeda Pharmaceuticals U.S.A., INC. | $115.43 | 2022-2025 | Entyvio, Gattex, Eohilia |
| Aimmune Therapeutics, INC. | $105.48 | 2024-2025 | Zenpep |
| Lilly USA, LLC | $99.49 | 2023-2025 | Omvoh, Taltz, Zepbound |
| Astrazeneca Pharmaceuticals LP | $96.59 | 2021-2025 | Saphnelo |
| Urovant Sciences INC | $94.84 | 2022 | |
| Cook Medical LLC | $93.30 | 2019 | |
| Procept Biorobotics Corporation | $89.85 | 2019-2025 | Aquabeam System |
| Telix Pharmaceuticals | $89.35 | 2023-2025 | Illuccix |
| Amgen INC. | $83.80 | 2019-2022 | |
| Halozyme INC | $78.80 | 2023 | |
| 180 Medical, INC. | $71.27 | 2023-2025 | Gentlecath |
| Therapeuticsmd, INC. | $65.78 | 2019-2021 | |
| Olympus Corporation of The Americas | $65.00 | 2023 | Itind System |
| Phathom Pharmaceuticals, INC. | $59.08 | 2024-2025 | Voquezna |
| Braintree Laboratories, INC. | $52.77 | 2023-2025 | Sutab, Suflave |
| Qol Medical, LLC | $52.35 | 2021-2023 | Sucraid |
| Ardelyx, INC. | $51.93 | 2024-2025 | Ibsrela |
| Verity Pharmaceuticals INC. | $51.39 | 2025 | Trelstar |
| C. R. Bard, INC. & Subsidiaries | $49.47 | 2019-2024 | Bard Urinary Drainage Bag |
| Tolmar, INC. | $45.79 | 2023 | |
| Intercept Pharmaceuticals, INC. | $42.62 | 2025 | |
| Hollister Incorporated | $41.60 | 2022 | |
| Abc Home Medical Supply, INC. | $40.73 | 2025 | |
| Acerus Pharmaceuticals Corporation | $40.50 | 2021-2022 | |
| Ucb, INC. | $38.33 | 2025 | Bimzelx |
| Palette Life Sciences, INC. | $33.05 | 2022 | |
| Kerecis Limited | $30.13 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Myovant Sciences INC. | $29.64 | 2022 | |
| Merck Sharp & Dohme LLC | $28.53 | 2024 | Keytruda |
| Karl Storz Endoscopy-America | $25.00 | 2019 | |
| Celltrion USA INC. | $22.29 | 2024 | Vegzelma |
| Olympus America INC. | $18.68 | 2023 | Itind System |
| Davol INC. | $18.64 | 2019 | |
| Tempus Ai, INC | $17.79 | 2025 | Xt Cdx |
| Nestle Healthcare Nutrition INC. | $17.32 | 2022 | |
| Dendreon Pharmaceuticals LLC | $14.82 | 2022 | |
| Clarus Therapeutics INC. | $14.01 | 2021 | |
| Medtronic Vascular, INC. | $12.44 | 2019 | |
| Intuitive Surgical, INC. | $10.99 | 2020 | |
| Travere Therapeutics, INC. | $9.62 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$6,600.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaspreet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.